Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04116658
Title First-in-Human, Phase 1b/2a Trial of a Multipeptide Therapeutic Vaccine in Patients With Progressive Glioblastoma (ROSALIE)
Acronym ROSALIE
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Enterome
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU

Facility Status City State Zip Country Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Centre Georges François Leclerc Dijon 21000 France Details
Hôpital Pitié-Salpétrière Paris 75013 France Details
Klinik und Poliklinik für Neurologie Universitätsklinikum Bonn Bonn 53105 Germany Details
Universitätsklinikum Frankfurt Goethe-Universität Dr. Senckenbergisches Institut für Neuroonkologie Frankfurt am Main 60528 Germany Details
Neurologische Klinik & Nationales Zentrum für Tumorenerkrankungen Heidelberg Universitätsklinikum Heidelberg Heidelberg 69120 Germany Details
Medizinische Fakultät Mannheim der Universität Heidelberg Mannheim 68167 Germany Details
Zentrum für Neuroonkologie Universitätsklinikum Tübingen Tübingen 72076 Germany Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Institit Catala D'Oncologia - Hospital Duran i Reynals Hospitalet De Llobregat 8908 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field